FDA review of drug names
This article was originally published in The Tan Sheet
Executive Summary
Drug Safety & Risk Management Advisory Committee will convene Dec. 4 to "discuss current screening methods to assess sound alike and look alike proprietary drug names, in order to reduce the incidence of medication errors." Meeting, previously scheduled for Sept. 18-19, was postponed for weather-related reasons. Session will follow-up on topics explored at a June meeting co-sponsored by FDA, PhRMA and the Institute for Safe Medication Practices (1"The Tan Sheet July 7, 2003, p. 12). Panel will meet at the Holiday Inn in Gaithersburg, from 8 am to 5 pm...